Provided by Tiger Trade Technology Pte. Ltd.

Moderna, Inc.

145.62
+1.851.29%
Post-market: 146.580.9600+0.66%19:59 EDT
Volume:8.83M
Turnover:1.29B
Market Cap:58.14B
PE:-18.19
High:148.93
Open:145.26
Low:142.30
Close:143.77
52wk High:176.66
52wk Low:22.28
Shares:399.24M
Float Shares:368.05M
Volume Ratio:0.86
T/O Rate:2.40%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-8.0076
EPS(LYR):-7.2600
ROE:-39.00%
ROA:-13.26%
PB:8.60
PE(LYR):-20.06

Loading ...

Top 10 Best-Performing US Stocks in August: Moderna Surges 156%, Palantir Leads AI Software Stocks

TradingKey
·
Sep 01

Cboe data suggests bullish flow in Moderna with shares up 0.71%

TIPRANKS
·
Sep 01

Moderna Stock (MRNA) Was the Best Performer in August

TIPRANKS
·
Sep 01

22 Best-Performing Stocks of August, as the Software Industry Continues Its Recovery

Dow Jones
·
Sep 01

Movement Alert|Moderna, Inc. Rises 3.44% in Regular Trading, Institutional Upgrades and Cancer Vaccine Breakthrough Fuel Intraday Rebound

Market Focus
·
Aug 31

Movement Alert|Moderna, Inc. Falls 3.25% in Pre-Market Trading, Convertible Note Dilution Fears Compounded by BioNTech Cancer Vaccine Setback

Market Focus
·
Aug 31

August Turmoil: Bessent's Intervention and the Quiet Reveal of Policy's Hidden Hand

Deep News
·
Aug 30

Pharma Industry Stares Down Biggest Patent Cliff in Decades

Dow Jones
·
Aug 29

US Stocks Weekly: AI Refuel

Reuters
·
Aug 29

BioNTech Stock Falls on Cancer Vaccine Setback Days After Moderna's Big Win

Dow Jones
·
Aug 29

BioNTech on Track for Worst Day Since March After Ending Colorectal Cancer Trial

Reuters
·
Aug 29

Top Calls On Wall Street: Nvidia, SpaceX, Moderna, TeraWulf , Amazon,Marvell, and More

Tiger Newspress
·
Aug 28

Moderna Stock Falls on $2B Notes Deal: Is the Cancer Rally Still Intact?

TradingKey
·
Aug 28

Movement Alert|Moderna, Inc. Falls 4.41% in Regular Trading, Convertible Note Offering Upsized to $2.6 Billion Intensifies Dilution Concerns

Market Focus
·
Aug 28

Argus Research Upgrades Moderna to Buy From Hold, $180 Price Target

MT Newswires Live
·
Aug 28

Moderna Announces Pricing of Upsized $2.6 Billion Offering of Convertible Senior Notes

Reuters
·
Aug 28

Moderna Price Target Announced at $180.00/Share by Argus Research

Dow Jones
·
Aug 28

U.S. Stocks on the MOVE-Cytokinetics, Moderna, Ulta Beauty

Reuters
·
Aug 28

Success After a Century of Failures: Inside Moderna and Merck's Cancer Vaccine Breakthrough

Reuters
·
Aug 28

Moderna Prices $2.6 Billion Convertible Notes due 2032

MT Newswires Live
·
Aug 28